← The SEC Ephemeris: the whole map
MEDRx USA, Inc.
In the graph: all 1 documents (2 pages).
- Application
- NDA 215029
- Ticker
- MEDRx USA, Inc.
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- July 11, 2024
From FDA letters and SEC filings. Not investment or medical advice.